Thorac Cardiovasc Surg 2007; 55(7): 460-461
DOI: 10.1055/s-2007-964947
Short Communications

© Georg Thieme Verlag KG Stuttgart · New York

Results of Multimodal Treatment of Two Patients with Thoracic Primitive Neuroectodermal Tumor. Is Surgery Really Helpful for Survival?

M. Z. Gunluoglu1 , H. V. Kara1 , A. Demir1 , S. I. Dincer1
  • 1Department of Thoracic Surgery, Yedikule Hospital for Diseases of the Chest and Thoracic Surgery, Istanbul, Turkey
Further Information

Publication History

Received September 5, 2006

Publication Date:
28 September 2007 (online)

Zoom Image

Introduction

Primitive neuroectodermal tumor (PNET) was first described by Askin et al. [[1]]. Previously, it was thought to originate from peripheral nerves and was referred to as neuroepithelioma [[2]]. Although the tumor was classified among the thoracic autonomic neurogenic tumors by Askin et al. [[1]], it does not produce biologically active substances which can be detected in blood or urine. PNET are classified as belonging to the group of malignant tumors with small round cells [[3]]. Most patients with PNET are adolescents or young adults, and the majority of them are younger than 30 years of age [[2]]. Despite combined chemoradiotherapy and surgical resection, the prognosis is generally poor due to local recurrence and distant metastases [[4]].

We report on two cases with PNET located in the thorax and present an overview of the clinical findings, treatment choices and outcomes for thoracic PNET on the basis of the data of two patients treated in our clinic.